At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease - 2 (CE-MARC2)
In Brief
A clinical study evaluating 3T CMR, SPECT, and 3 other interventions for Coronary Heart Disease. Completed, enrolled 1,202 participants across 6 sites.
Detailed Summary
CE-MARC 2 is a randomised controlled trial to determine diagnosis and patient management in patients presenting to outpatient clinics with suspected stable angina. Cardiac Magnetic Resonance Imaging (at 3Tesla) will be evaluated prospectively against current best clinical practice (defined by international guidelines). The study hypothesis is that 3Tesla CMR-guided management of patients with suspected stable angina is superior to current clinical practice based on 1) the principles of the National Institutes for Clinical Excellence (NICE) CG95 guidelines (2010); 2) SPECT AHA appropriateness criteria, in terms of avoiding study-defined unnecessary invasive coronary angiography.
Study Details
Timeline
Interventions
3Tesla Cardiac Magnetic Resonance Imaging
SPECT: Single Photon Emission Computed Tomography
CT calcium score
CT coronary angiography
X-Ray coronary angiography